CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

CUSIP: 18914F103

Q3 2023 13F Holders as of 30 Sep 2023

Holder snapshot 7 signals
Share change
-3,150,114
Put/Call ratio
48%
SEC-reported price per share
$1.08
Number of holders
138
Value change
-$3,078,475
Number of buys
57
Open additional details 1 more signal available
Number of sells
57
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
416,598,522

Security key

18914F103

Report period

Q3 2023

Institutions

138

Top holders

10

Ownership snapshot

Top reported holders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Chamath Palihapitiya
Disclosed value leader
Chamath Palihapitiya
Comparable rows
0/15
Latest evidence
30 Jun 2023
3/4/5 13F Highest disclosed value: $29,544,657 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Chamath Palihapitiya has the largest disclosed position value at $29.54M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Chamath Palihapitiya's linked filing trail.
Disclosed position value Top 5
Chamath Palihapitiya $29.54M
GREENOAKS LLC $24.47M
VANGUARD GROUP INC $28.2M
RENAISSANCE TECHNOLOGIES LLC $7.94M
BlackRock Finance, Inc. $6.97M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Chamath Palihapitiya
3/4/5
FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner
—
denominator unverified
$29,544,657
30,147,610 shares
— 07 Jul 2021
GREENOAKS LLC
3/4/5
Other*, 10%+ Owner
—
denominator unverified
$24,466,828
25,754,556 shares
— 22 Nov 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$28,200,069
31,434,700 shares
— 30 Jun 2023
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$7,937,000
8,847,780 shares
— 30 Jun 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$6,972,354
7,772,104 shares
— 30 Jun 2023
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$4,797,935
5,348,273 shares
— 30 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
138
Shares
93,620,098
Rows available
138
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
140
Q3 2023 holders
138
Holder diff
-2
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 value Q3 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .